EUVIMEDOpdag EUVIMED
Crossref

Engineered HSP90 ‐ MP65 Bivalent Fusion Antigen: A Novel Vaccine Candidate Against Invasive Candidiasis

Leszek Wawiórka iD

Proteins: Structure, Function, and Bioinformatics · 2026-12 · 94 (12) · 1886-1901

DOI: 10.1002/prot.70152 ↗

At a glance

Journal article in Proteins: Structure, Function, and Bioinformatics, published online on 2026-06-18. Written by Leszek Wawiórka. Institution: Department of Molecular Biology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Lublin, Poland. Major MEDLINE topics: Fungal Vaccines, HSP90 Heat-Shock Proteins, Candidiasis, Invasive, Fungal Proteins. Cited 1 times so far (Crossref); 69 references. Funded by: Union of Lublin Universities ZUL.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Invasive candidiasis represents a critical global health challenge, causing approximately 6.5 million bloodstream infections annually with mortality rates exceeding 60%. The emergence of multidrug‐resistant Candida strains necessitates novel prophylactic strategies, with subunit vaccines offering a rational alternative to conventional antifungals. This study presents a structure‐guided approach to engineer a novel, optimized HSP90‐MP65 bivalent fusion protein as a vaccine candidate against invasive candidiasis. The central hypothesis posits that direct genetic fusion of the immunostimulatory HSP90 domain to the MP65 mannoprotein antigen creates a bifunctional molecule with enhanced antigen processing and presentation properties compared to co‐administration of separate components. An integrative computational framework combining deep learning‐based structure prediction, consensus B‐cell and T‐cell epitope mapping, rational sequence optimization (ProteinMPNN), and comprehensive biophysical characterization was employed to design multiple fusion constructs and systematically evaluate their structural integrity, conformational stability, aggregation propensity, and immunogenic potential. As a result, the most promising, rationally designed lead candidate has been designed and comprehensively optimized. The lead candidate combines superior thermodynamic preserved epitope accessibility while preserving all immunogenic features. Molecular docking and binding affinity predictions confirm maintained interactions with pattern recognition receptors and MHC molecules. This structure‐based engineering approach yielded a manufacturable fusion antigen with preserved immunostimulatory domains, providing a molecular blueprint for bivalent vaccine development against fungal pathogens.

Subjects

MeSH terms (MEDLINE)

Fungal VaccinesHSP90 Heat-Shock ProteinsCandidiasis, InvasiveFungal ProteinsAntigens, FungalRecombinant Fusion ProteinsProtein EngineeringProtein Subunit VaccinesEpitopes, T-LymphocyteHumansCandida albicansEpitopes, B-LymphocyteMolecular Docking SimulationAnimalsEpitope Mapping

Author keywords

Candida spp.HSP90MP65computer‐aided rational vaccine designdeep learningepitope predictionfusion antigenprotein engineering

Substances

Recombinant Fusion ProteinsFungal VaccinesHSP90 Heat-Shock ProteinsFungal ProteinsProtein Subunit VaccinesAntigens, FungalEpitopes, T-LymphocyteEpitopes, B-Lymphocyte

Authors and institutions

  • Department of Molecular Biology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Lublin, Poland.
  • Bioinformatics and Biostatistics Laboratory, Institute of Biological Sciences, Maria Curie-Skłodowska University, Lublin, Poland.

ORCID profiles: Leszek Wawiórka

Funding

  • Union of Lublin Universities ZUL

Cite

APA

Wawiórka, L. (2026). Engineered HSP90 ‐ MP65 Bivalent Fusion Antigen: A Novel Vaccine Candidate Against Invasive Candidiasis. Proteins: Structure, Function, and Bioinformatics, 94(12), 1886-1901. https://doi.org/10.1002/prot.70152

Vancouver

Wawiórka L. Engineered HSP90 ‐ MP65 Bivalent Fusion Antigen: A Novel Vaccine Candidate Against Invasive Candidiasis. Proteins: Structure, Function, and Bioinformatics. 2026;94(12):1886-1901. doi:10.1002/prot.70152

BibTeX
@article{Wawirka2026,
  author = {Wawiórka, Leszek},
  title = {Engineered HSP90 ‐ MP65 Bivalent Fusion Antigen: A Novel Vaccine Candidate Against Invasive Candidiasis},
  journal = {Proteins: Structure, Function, and Bioinformatics},
  year = {2026},
  volume = {94},
  number = {12},
  pages = {1886--1901},
  doi = {10.1002/prot.70152}
}
Start for free →